• Press Release

Mount Sinai Health System Names Stephen D. Savas, MBA, Executive Vice President and Chief of System Development and Strategic Initiatives

  • New York, NY
  • (November 03, 2025)

The Mount Sinai Health System has announced the appointment of Stephen D. Savas, MBA, as Executive Vice President and Chief of System Development and Strategic Initiatives, effective Saturday, November 1.  

Mr. Savas will be responsible for working with the executive team at the Health System to drive long-term strategy, system development, and execution excellence. His role will focus on the alignment of strategy across clinical care, research, education, and innovation. He will work with the organization’s leadership to further implement its newly adopted “One Mount Sinai” transformation, which reinforces a center-led model to ensure that each component part serves to optimize the whole of Mount Sinai.  

“This new role will allow us to identify and drive enterprise-level growth opportunities through strategic partnerships and innovative business models. I know Mr. Savas to be a terrific collaborator and believe that he will help us to continue to evolve as an integrated and aligned organization,” said Brendan G. Carr, MD, MA, MS, Chief Executive Officer and Professor and Kenneth L. Davis, MD, Distinguished Chair of the Mount Sinai Health System.  

Prior to joining the Health System, Mr. Savas advised the organization on high-level management strategies. He brings more than 30 years of experience in health care strategy, operations, and technology to the role. He was previously employed by Accenture, where he has been a managing director since 2013 and the North America Health Lead since 2023, helping payers and providers define growth and innovation strategies and improve the cost and quality of providing care.   

“I’m excited to join Mount Sinai and help realize strategic and operational opportunities that further the mission to advance medicine through world-leading education and research while providing compassionate care for the communities we serve,” said Mr. Savas. 

With diverse experience across health care, he has assessed and executed numerous merger and joint venture opportunities, and managed partnerships with leading technology companies. Throughout his career, he has co-authored papers on a wide range of innovative topics, most recently on generative AI in health care.  

Before joining Accenture, Mr. Savas was a leader of McKinsey & Company’s health care information technology practice from 2007 to 2013; he previously worked in equity research at Goldman Sachs and the pharmaceutical industry at Pfizer. He was also co-founder of Provation Medical, a clinical software company. Mr. Savas holds an MBA from the Wharton School of the University of Pennsylvania.  


About the Mount Sinai Health System

Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. The Health System includes approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses across seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, a school of nursing, and schools of medicine and graduate school of biomedical sciences.  

As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.  

Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York and recognized as one of the world’s top Smart Hospital by Newsweek. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools for National Institutes of Health (NIH) funding and No. 1 among freestanding medical schools, reflecting the strength of its scientific enterprise and leadership in biomedical research. 

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube. To listen to news and stories from Mount Sinai, visit the Mount Sinai Podcast Network.